Jose Diaz-Miron
Concepts (243)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Gastric Bypass | 2 | 2026 | 115 | 1.670 |
Why?
| | Extracorporeal Membrane Oxygenation | 2 | 2025 | 370 | 1.300 |
Why?
| | Gastrostomy | 7 | 2026 | 124 | 1.260 |
Why?
| | Appendicitis | 4 | 2026 | 151 | 1.250 |
Why?
| | Surgeons | 6 | 2025 | 351 | 1.180 |
Why?
| | Wounds and Injuries | 4 | 2026 | 959 | 1.150 |
Why?
| | Funnel Chest | 5 | 2026 | 31 | 1.140 |
Why?
| | Intestine, Small | 8 | 2017 | 160 | 1.090 |
Why?
| | Intubation, Gastrointestinal | 2 | 2026 | 76 | 0.950 |
Why?
| | Preoperative Care | 2 | 2026 | 396 | 0.940 |
Why?
| | Bicycling | 1 | 2026 | 117 | 0.880 |
Why?
| | Minimally Invasive Surgical Procedures | 5 | 2026 | 196 | 0.870 |
Why?
| | Accidents, Traffic | 1 | 2026 | 193 | 0.860 |
Why?
| | Renal Insufficiency | 1 | 2025 | 173 | 0.770 |
Why?
| | Central Venous Catheters | 1 | 2023 | 53 | 0.760 |
Why?
| | Intestinal Atresia | 1 | 2023 | 16 | 0.750 |
Why?
| | Enteral Nutrition | 7 | 2026 | 212 | 0.750 |
Why?
| | Catheter-Related Infections | 1 | 2023 | 101 | 0.740 |
Why?
| | Child | 32 | 2026 | 22693 | 0.730 |
Why?
| | Needs Assessment | 1 | 2025 | 404 | 0.730 |
Why?
| | Catheterization, Central Venous | 1 | 2023 | 121 | 0.700 |
Why?
| | Myofibromatosis | 1 | 2021 | 10 | 0.700 |
Why?
| | Retrospective Studies | 26 | 2026 | 17438 | 0.700 |
Why?
| | Clinical Decision-Making | 1 | 2025 | 365 | 0.690 |
Why?
| | Cardiopulmonary Resuscitation | 1 | 2025 | 334 | 0.690 |
Why?
| | Esophageal Atresia | 3 | 2026 | 32 | 0.670 |
Why?
| | Heart Arrest | 1 | 2025 | 411 | 0.660 |
Why?
| | Tracheoesophageal Fistula | 3 | 2026 | 38 | 0.660 |
Why?
| | Appendectomy | 3 | 2026 | 93 | 0.640 |
Why?
| | Decision Making | 2 | 2025 | 993 | 0.620 |
Why?
| | Adaptation, Physiological | 6 | 2017 | 568 | 0.610 |
Why?
| | Infant | 18 | 2026 | 10114 | 0.600 |
Why?
| | Infant, Newborn | 10 | 2026 | 6460 | 0.570 |
Why?
| | Postoperative Complications | 9 | 2026 | 3034 | 0.550 |
Why?
| | Child, Preschool | 16 | 2026 | 11913 | 0.540 |
Why?
| | Pregnancy Complications, Infectious | 1 | 2023 | 438 | 0.540 |
Why?
| | Neovascularization, Physiologic | 3 | 2015 | 189 | 0.510 |
Why?
| | Telemedicine | 3 | 2026 | 966 | 0.500 |
Why?
| | Short Bowel Syndrome | 5 | 2017 | 24 | 0.460 |
Why?
| | Clinical Protocols | 3 | 2026 | 282 | 0.450 |
Why?
| | Male | 34 | 2026 | 73396 | 0.430 |
Why?
| | Lung Diseases | 1 | 2022 | 787 | 0.430 |
Why?
| | Adolescent | 18 | 2026 | 22557 | 0.430 |
Why?
| | Humans | 48 | 2026 | 146342 | 0.420 |
Why?
| | Coronary Aneurysm | 1 | 2014 | 17 | 0.420 |
Why?
| | Female | 33 | 2026 | 79499 | 0.410 |
Why?
| | Quality Improvement | 1 | 2023 | 1354 | 0.400 |
Why?
| | Length of Stay | 5 | 2026 | 1358 | 0.390 |
Why?
| | Thoracic Injuries | 1 | 2014 | 69 | 0.390 |
Why?
| | Baseball | 1 | 2014 | 57 | 0.390 |
Why?
| | Hepatoblastoma | 2 | 2024 | 52 | 0.390 |
Why?
| | Postoperative Care | 2 | 2026 | 301 | 0.390 |
Why?
| | Specialties, Surgical | 2 | 2025 | 88 | 0.380 |
Why?
| | Hemostasis | 1 | 2013 | 100 | 0.370 |
Why?
| | Hematopoiesis | 1 | 2013 | 195 | 0.360 |
Why?
| | Surgical Wound Infection | 2 | 2026 | 349 | 0.350 |
Why?
| | Magnetic Resonance Imaging | 2 | 2026 | 3926 | 0.340 |
Why?
| | Wounds, Nonpenetrating | 1 | 2014 | 305 | 0.330 |
Why?
| | Patient Education as Topic | 2 | 2026 | 770 | 0.310 |
Why?
| | Laparoscopy | 4 | 2026 | 487 | 0.290 |
Why?
| | Lung | 1 | 2022 | 4122 | 0.270 |
Why?
| | Treatment Outcome | 8 | 2026 | 11821 | 0.270 |
Why?
| | Intestinal Mucosa | 5 | 2017 | 666 | 0.260 |
Why?
| | Incidence | 2 | 2026 | 2936 | 0.260 |
Why?
| | Liver Neoplasms | 2 | 2024 | 776 | 0.260 |
Why?
| | Analgesics, Opioid | 2 | 2026 | 1221 | 0.250 |
Why?
| | Drug Prescriptions | 2 | 2026 | 314 | 0.240 |
Why?
| | Practice Patterns, Physicians' | 2 | 2026 | 1408 | 0.240 |
Why?
| | Abdominal Abscess | 1 | 2026 | 28 | 0.240 |
Why?
| | Prospective Studies | 6 | 2026 | 8123 | 0.240 |
Why?
| | Trauma Centers | 3 | 2026 | 441 | 0.240 |
Why?
| | Gastropexy | 1 | 2026 | 4 | 0.230 |
Why?
| | Receptor, IGF Type 1 | 2 | 2017 | 64 | 0.230 |
Why?
| | Insulin-Like Growth Factor II | 2 | 2017 | 24 | 0.230 |
Why?
| | Intercostal Nerves | 1 | 2025 | 2 | 0.230 |
Why?
| | Esophageal Stenosis | 1 | 2026 | 60 | 0.230 |
Why?
| | Retinoblastoma Protein | 2 | 2017 | 63 | 0.230 |
Why?
| | Hypesthesia | 1 | 2025 | 21 | 0.230 |
Why?
| | Hernia, Inguinal | 1 | 2025 | 47 | 0.220 |
Why?
| | Gastroschisis | 1 | 2025 | 32 | 0.220 |
Why?
| | Operative Time | 1 | 2026 | 195 | 0.220 |
Why?
| | Herniorrhaphy | 1 | 2025 | 87 | 0.220 |
Why?
| | Cryosurgery | 1 | 2025 | 46 | 0.220 |
Why?
| | Sutures | 1 | 2025 | 66 | 0.220 |
Why?
| | Caregivers | 2 | 2026 | 1080 | 0.210 |
Why?
| | Chemokine CXCL5 | 2 | 2015 | 20 | 0.210 |
Why?
| | Trisomy 18 Syndrome | 1 | 2024 | 5 | 0.210 |
Why?
| | Anastomotic Leak | 1 | 2024 | 46 | 0.210 |
Why?
| | Intestinal Volvulus | 1 | 2024 | 23 | 0.210 |
Why?
| | Suture Techniques | 1 | 2025 | 138 | 0.210 |
Why?
| | Hospitals, Pediatric | 2 | 2025 | 561 | 0.210 |
Why?
| | Guideline Adherence | 2 | 2026 | 594 | 0.210 |
Why?
| | Competency-Based Education | 1 | 2025 | 83 | 0.200 |
Why?
| | Critical Pathways | 1 | 2025 | 104 | 0.200 |
Why?
| | Tomography, X-Ray Computed | 3 | 2026 | 2786 | 0.200 |
Why?
| | Gastric Fistula | 1 | 2024 | 9 | 0.200 |
Why?
| | Health Literacy | 1 | 2026 | 183 | 0.200 |
Why?
| | Pandemics | 2 | 2022 | 1707 | 0.190 |
Why?
| | Pneumatosis Cystoides Intestinalis | 1 | 2023 | 21 | 0.190 |
Why?
| | Enoxaparin | 1 | 2023 | 68 | 0.180 |
Why?
| | Pain Management | 1 | 2026 | 421 | 0.180 |
Why?
| | Perioperative Care | 1 | 2025 | 235 | 0.180 |
Why?
| | False Positive Reactions | 1 | 2022 | 124 | 0.170 |
Why?
| | Scalp | 1 | 2021 | 38 | 0.170 |
Why?
| | Interviews as Topic | 1 | 2025 | 930 | 0.170 |
Why?
| | Photography | 1 | 2021 | 120 | 0.160 |
Why?
| | Fellowships and Scholarships | 1 | 2025 | 355 | 0.160 |
Why?
| | Intestinal Obstruction | 1 | 2021 | 54 | 0.160 |
Why?
| | Operating Rooms | 1 | 2022 | 145 | 0.160 |
Why?
| | Carcinoma, Hepatocellular | 1 | 2024 | 370 | 0.150 |
Why?
| | Healthcare Disparities | 2 | 2024 | 733 | 0.150 |
Why?
| | Transgender Persons | 1 | 2023 | 213 | 0.150 |
Why?
| | Education, Medical, Graduate | 1 | 2025 | 568 | 0.150 |
Why?
| | Referral and Consultation | 1 | 2026 | 881 | 0.150 |
Why?
| | Thrombosis | 1 | 2023 | 398 | 0.150 |
Why?
| | Pregnancy Outcome | 1 | 2023 | 503 | 0.150 |
Why?
| | Neuroblastoma | 2 | 2011 | 177 | 0.140 |
Why?
| | Mice, Knockout | 5 | 2017 | 3125 | 0.130 |
Why?
| | Cardiac Surgical Procedures | 1 | 2024 | 611 | 0.130 |
Why?
| | Qualitative Research | 1 | 2025 | 1734 | 0.130 |
Why?
| | Feasibility Studies | 1 | 2022 | 1135 | 0.130 |
Why?
| | Patient Satisfaction | 1 | 2021 | 706 | 0.130 |
Why?
| | Infant, Premature | 1 | 2021 | 622 | 0.120 |
Why?
| | Sensitivity and Specificity | 1 | 2022 | 1998 | 0.120 |
Why?
| | Pediatrics | 1 | 2025 | 1124 | 0.120 |
Why?
| | Curriculum | 1 | 2023 | 1079 | 0.120 |
Why?
| | Clinical Competence | 1 | 2025 | 1272 | 0.120 |
Why?
| | Head and Neck Neoplasms | 1 | 2021 | 563 | 0.120 |
Why?
| | Heart Defects, Congenital | 1 | 2024 | 923 | 0.120 |
Why?
| | Parents | 1 | 2025 | 1394 | 0.120 |
Why?
| | Burnout, Professional | 1 | 2022 | 493 | 0.110 |
Why?
| | Mice, Inbred C57BL | 6 | 2015 | 6034 | 0.110 |
Why?
| | Thoracoscopy | 2 | 2026 | 60 | 0.110 |
Why?
| | Anastomosis, Surgical | 2 | 2026 | 164 | 0.110 |
Why?
| | Enterocytes | 1 | 2014 | 13 | 0.110 |
Why?
| | Intestinal Absorption | 1 | 2015 | 103 | 0.100 |
Why?
| | Extracorporeal Circulation | 1 | 2013 | 15 | 0.100 |
Why?
| | Vitamin K Deficiency Bleeding | 1 | 2013 | 5 | 0.100 |
Why?
| | Anti-Bacterial Agents | 1 | 2025 | 1942 | 0.100 |
Why?
| | Digestive System Surgical Procedures | 1 | 2014 | 115 | 0.100 |
Why?
| | Disseminated Intravascular Coagulation | 1 | 2013 | 34 | 0.100 |
Why?
| | Dietary Proteins | 1 | 2014 | 135 | 0.100 |
Why?
| | Body Composition | 2 | 2014 | 689 | 0.100 |
Why?
| | Injury Severity Score | 2 | 2026 | 572 | 0.100 |
Why?
| | Reoperation | 2 | 2026 | 645 | 0.090 |
Why?
| | Intracranial Hemorrhages | 1 | 2013 | 106 | 0.090 |
Why?
| | Diet, High-Fat | 1 | 2014 | 267 | 0.090 |
Why?
| | ErbB Receptors | 1 | 2015 | 636 | 0.090 |
Why?
| | Weight Gain | 1 | 2014 | 562 | 0.080 |
Why?
| | Proto-Oncogene Proteins c-mdm2 | 1 | 2011 | 66 | 0.080 |
Why?
| | Real-Time Polymerase Chain Reaction | 3 | 2017 | 334 | 0.080 |
Why?
| | Imidazoles | 1 | 2011 | 245 | 0.080 |
Why?
| | Pregnancy | 1 | 2023 | 7230 | 0.070 |
Why?
| | Neovascularization, Pathologic | 1 | 2011 | 287 | 0.070 |
Why?
| | Angiogenesis Inhibitors | 1 | 2011 | 239 | 0.070 |
Why?
| | Bacteria | 1 | 2014 | 766 | 0.070 |
Why?
| | Piperazines | 1 | 2011 | 368 | 0.070 |
Why?
| | Patient Readmission | 2 | 2025 | 778 | 0.070 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2011 | 545 | 0.070 |
Why?
| | Animals | 9 | 2017 | 38107 | 0.070 |
Why?
| | RNA | 1 | 2014 | 926 | 0.060 |
Why?
| | Microbiota | 1 | 2014 | 725 | 0.060 |
Why?
| | Neoplasm Proteins | 1 | 2009 | 444 | 0.060 |
Why?
| | United States | 4 | 2026 | 16136 | 0.060 |
Why?
| | Parenteral Nutrition, Total | 1 | 2026 | 27 | 0.060 |
Why?
| | Drainage | 1 | 2026 | 187 | 0.060 |
Why?
| | Thoracic Wall | 1 | 2025 | 22 | 0.060 |
Why?
| | Selenium | 1 | 2025 | 48 | 0.060 |
Why?
| | Cellulitis | 1 | 2025 | 55 | 0.060 |
Why?
| | Postoperative Period | 2 | 2017 | 355 | 0.050 |
Why?
| | Mice | 7 | 2017 | 18297 | 0.050 |
Why?
| | Antibodies, Monoclonal, Humanized | 1 | 2011 | 992 | 0.050 |
Why?
| | Young Adult | 3 | 2026 | 14330 | 0.050 |
Why?
| | Gene Expression Regulation | 1 | 2014 | 2599 | 0.050 |
Why?
| | Asymptomatic Diseases | 1 | 2024 | 102 | 0.050 |
Why?
| | Radiation Exposure | 1 | 2024 | 62 | 0.050 |
Why?
| | Antibiotic Prophylaxis | 1 | 2025 | 140 | 0.050 |
Why?
| | Random Allocation | 2 | 2014 | 366 | 0.050 |
Why?
| | Shock | 1 | 2024 | 101 | 0.050 |
Why?
| | Disease Models, Animal | 4 | 2014 | 4580 | 0.050 |
Why?
| | Membrane Proteins | 1 | 2009 | 1130 | 0.050 |
Why?
| | Gender Identity | 1 | 2023 | 132 | 0.050 |
Why?
| | Disposable Equipment | 1 | 2022 | 25 | 0.050 |
Why?
| | Recurrence | 1 | 2025 | 1133 | 0.050 |
Why?
| | Intensive Care Units, Neonatal | 1 | 2025 | 295 | 0.040 |
Why?
| | Heparin | 1 | 2023 | 247 | 0.040 |
Why?
| | Adhesives | 1 | 2021 | 15 | 0.040 |
Why?
| | Adenoidectomy | 1 | 2022 | 82 | 0.040 |
Why?
| | Blood Coagulation | 1 | 2023 | 267 | 0.040 |
Why?
| | Contrast Media | 1 | 2024 | 493 | 0.040 |
Why?
| | Tissue Adhesions | 1 | 2021 | 32 | 0.040 |
Why?
| | Hospital Costs | 1 | 2022 | 131 | 0.040 |
Why?
| | Cell Proliferation | 3 | 2015 | 2502 | 0.040 |
Why?
| | Cardiology | 1 | 2024 | 363 | 0.040 |
Why?
| | Immunohistochemistry | 2 | 2014 | 1712 | 0.040 |
Why?
| | Intestines | 1 | 2023 | 351 | 0.040 |
Why?
| | Medicaid | 1 | 2024 | 477 | 0.040 |
Why?
| | Socioeconomic Factors | 1 | 2024 | 1327 | 0.040 |
Why?
| | Pilot Projects | 1 | 2025 | 1888 | 0.040 |
Why?
| | Surveys and Questionnaires | 2 | 2022 | 6073 | 0.040 |
Why?
| | Practice Guidelines as Topic | 1 | 2026 | 1591 | 0.030 |
Why?
| | Databases, Factual | 1 | 2024 | 1493 | 0.030 |
Why?
| | Apoptosis | 2 | 2015 | 2439 | 0.030 |
Why?
| | RNA, Messenger | 2 | 2014 | 2791 | 0.030 |
Why?
| | Sodium-Glucose Transporter 1 | 1 | 2014 | 11 | 0.030 |
Why?
| | Glucose Transporter Type 2 | 1 | 2014 | 16 | 0.030 |
Why?
| | Fish Oils | 1 | 2014 | 27 | 0.030 |
Why?
| | Tissue and Organ Harvesting | 1 | 2014 | 69 | 0.030 |
Why?
| | Time Factors | 1 | 2024 | 7109 | 0.020 |
Why?
| | Tamoxifen | 1 | 2014 | 193 | 0.020 |
Why?
| | Microcirculation | 1 | 2014 | 142 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2024 | 5899 | 0.020 |
Why?
| | Attitude of Health Personnel | 1 | 2021 | 1219 | 0.020 |
Why?
| | Fatty Acids, Omega-3 | 1 | 2014 | 145 | 0.020 |
Why?
| | Colorado | 1 | 2023 | 4595 | 0.020 |
Why?
| | Cell Line, Tumor | 2 | 2011 | 3545 | 0.020 |
Why?
| | Linear Models | 1 | 2014 | 857 | 0.020 |
Why?
| | Blotting, Western | 1 | 2014 | 1177 | 0.020 |
Why?
| | Energy Intake | 1 | 2014 | 507 | 0.020 |
Why?
| | Up-Regulation | 1 | 2014 | 841 | 0.020 |
Why?
| | Bevacizumab | 1 | 2011 | 169 | 0.020 |
Why?
| | Risk Factors | 1 | 2024 | 10921 | 0.020 |
Why?
| | Mice, Nude | 1 | 2011 | 668 | 0.020 |
Why?
| | Mitogen-Activated Protein Kinase 3 | 1 | 2009 | 134 | 0.020 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2011 | 299 | 0.020 |
Why?
| | Adult | 2 | 2023 | 41087 | 0.020 |
Why?
| | Down-Regulation | 1 | 2011 | 614 | 0.020 |
Why?
| | Mitogen-Activated Protein Kinase 1 | 1 | 2009 | 170 | 0.020 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 1 | 2009 | 174 | 0.020 |
Why?
| | Epithelial Cells | 1 | 2015 | 1119 | 0.020 |
Why?
| | Neoplasm Metastasis | 1 | 2011 | 693 | 0.020 |
Why?
| | Weight Loss | 1 | 2014 | 858 | 0.020 |
Why?
| | Xenograft Model Antitumor Assays | 1 | 2011 | 930 | 0.020 |
Why?
| | Transfection | 1 | 2009 | 916 | 0.020 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2011 | 530 | 0.020 |
Why?
| | Base Sequence | 1 | 2009 | 2123 | 0.010 |
Why?
| | Biomarkers | 1 | 2017 | 4340 | 0.010 |
Why?
| | Molecular Sequence Data | 1 | 2009 | 2838 | 0.010 |
Why?
| | Phosphorylation | 1 | 2009 | 1724 | 0.010 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2011 | 1432 | 0.010 |
Why?
| | Follow-Up Studies | 1 | 2014 | 5439 | 0.010 |
Why?
| | Computational Biology | 1 | 2009 | 678 | 0.010 |
Why?
| | Cells, Cultured | 1 | 2009 | 4118 | 0.010 |
Why?
|
|
Diaz-Miron's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|